Key statistics
As of last trade, Lexaria Bioscience Corp (LEXX:NAQ) traded at 3.24, 280.59% above the 52 week low of 0.85 set on Oct 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.23 |
---|---|
High | 3.30 |
Low | 3.16 |
Bid | 3.22 |
Offer | 3.26 |
Previous close | 3.22 |
Average volume | 86.23k |
---|---|
Shares outstanding | 15.81m |
Free float | 14.27m |
P/E (TTM) | -- |
Market cap | 50.91m USD |
EPS (TTM) | -0.4455 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 17:02 BST.
More ▼
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of Proprietary Platform in Multibillion-Dollar GLP-1 Drug Space
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-Delivery Platform for Improved Efficacy of GLP-1 Drugs